Skip Navigation

NCI-COG PEDIATRIC MATCH MOLECULAR ANALYSIS FOR THERAPY CHOICE- PHASE 2 SUBPROTOCOL OF LOXO-101 LAROTRECTINIB IN PATIENTS WITH TUMORS HARBORING ACTIONABLE NTRK FUSIONS

Brief Summary

Type:
Multiple Sites (Solid Tumors)

Study Type:
Treatment

Phase:
II

ClinicalTrials.gov Identifier:
NCT03213704

Study #:
CMH - APEC1621A

Start Date:
Nov 26, 2019

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT03213704

View Complete Trial Details & Eligibility at ClinicalTrials.gov